ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹0.11 Cr | ₹-8.27 Cr | ₹-6.36 Cr | ₹-1.59 Cr | ₹-1.71 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹-8.27 Cr |
| Mar2023 | ₹-6.36 Cr |
| Mar2022 | ₹-1.59 Cr |
| Mar2021 | ₹-1.71 Cr |
How is Cash Flow from Financing Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.11 Cr | Positive | |
| Mar2024 | ₹-8.27 Cr | Negative | |
| Mar2023 | ₹-6.36 Cr | Negative | |
| Mar2022 | ₹-1.59 Cr | Negative | |
| Mar2021 | ₹-1.71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹392.2 Cr | -3.5% | 0.1% | -20.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -3.5% |
0.1% |
-20.5% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses